BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9618849)

  • 1. Assessment of first-trimester nuchal translucency by daily reference intervals.
    Yagel S; Anteby EY; Rosen L; Yaffe E; Rabinowitz R; Tadmor O
    Ultrasound Obstet Gynecol; 1998 Apr; 11(4):262-5. PubMed ID: 9618849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and management of fetal nuchal translucency.
    Jackson M; Rose NC
    Semin Roentgenol; 1998 Oct; 33(4):333-8. PubMed ID: 9800243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased nuchal translucency as a marker for fetal chromosomal defects.
    Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
    N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination.
    Josefsson A; Molander E; Selbing A
    Acta Obstet Gynecol Scand; 1998 May; 77(5):497-9. PubMed ID: 9654169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and older.
    Zoppi MA; Ibba RM; Putzolu M; Floris M; Monni G
    Obstet Gynecol; 2001 Jun; 97(6):916-20. PubMed ID: 11384696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population?
    Chasen ST; McCullough LB; Chervenak FA
    Am J Obstet Gynecol; 2004 Mar; 190(3):769-74. PubMed ID: 15042012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The optimal gestational age to examine fetal anatomy and measure nuchal translucency in the first trimester.
    Whitlow BJ; Economides DL
    Ultrasound Obstet Gynecol; 1998 Apr; 11(4):258-61. PubMed ID: 9618848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester umbilical cord diameter: a novel marker of fetal aneuploidy.
    Ghezzi F; Raio L; Di Naro E; Franchi M; Buttarelli M; Schneider H
    Ultrasound Obstet Gynecol; 2002 Mar; 19(3):235-9. PubMed ID: 11936081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of three-dimensional ultrasound to nuchal translucency measurement in early pregnancy (10-14 weeks): a preliminary study.
    Chung BL; Kim HJ; Lee KH
    Ultrasound Obstet Gynecol; 2000 Feb; 15(2):122-5. PubMed ID: 10775994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of nuchal cord on nuchal translucency measurement at 10-14 weeks.
    Schaefer M; Laurichesse-Delmas H; Ville Y
    Ultrasound Obstet Gynecol; 1998 Apr; 11(4):271-3. PubMed ID: 9618851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pregnancy outcome in fetuses with increased nuchal translucency thickness at 10-14 weeks of pregnancy].
    Maymon R; Dreazen E; Tovbin Y; Weinraub Z; Herman A
    Harefuah; 1999 Jun; 136(11):851-5, 916, 915. PubMed ID: 10955127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal heart rate and nuchal translucency in detecting chromosomal abnormalities other than Down syndrome.
    Martinez JM; Echevarría M; Borrell A; Puerto B; Ojuel J; Fortuny A
    Obstet Gynecol; 1998 Jul; 92(1):68-71. PubMed ID: 9649096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nuchal translucency measurement--non invasive ultrasound screening for fetal abnormalities. Part I].
    Baś-Budecka E; Suzin J; Lipecka-Kidawska E; Sieroszewski P
    Ginekol Pol; 2004 Mar; 75(3):187-91. PubMed ID: 15181875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nuchal translucency measurement--non invasive ultrasound screening for fetal abnormalities. Part II].
    Sieroszewski P; Baś-Budecka E
    Ginekol Pol; 2004 Mar; 75(3):192-6. PubMed ID: 15181876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nuchal cord and nuchal translucency measurements between 10th and 14th weeks of gestation].
    Czekierdowski A; Sodowski K; Cnota W; Kraczkowski J
    Ginekol Pol; 2001 Dec; 72(12A):1596-601. PubMed ID: 11883322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
    Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeatability of measurement of fetal nuchal translucency thickness.
    Pandya PP; Altman DG; Brizot ML; Pettersen H; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 May; 5(5):334-7. PubMed ID: 7614139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester Down's syndrome screening using nuchal translucency: a prospective study in patients undergoing chorionic villus sampling.
    Brambati B; Cislaghi C; Tului L; Alberti E; Amidani M; Colombo U; Zuliani G
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):9-14. PubMed ID: 7850598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-trimester ultrasound screening for fetal aneuploidies in women over 35 and under 35 years of age.
    Szabó J; Gellén J; Szemere G
    Ultrasound Obstet Gynecol; 1995 Mar; 5(3):161-3. PubMed ID: 7788489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B; Slack A; Wathen NC
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.